Memorial Sloan Kettering Cancer Center (MSK) Announces 2023 Awards and Appointments

• by EVOMT
• 2023-02-13

Memorial Sloan Kettering Cancer Center

MemorialSloan-Kettering Cancer Center

Hospital Introduction and Honors

The Memorial Sloan Kettering Cancer Center is the world's oldest and largest private cancer center

For a century, the center has been dedicated to patient care, research innovation, and understanding, diagnosing, and treating cancer. As the best cancer center in the United States, the Memorial Sloan Kettering Cancer Center is one of the 41 comprehensive cancer centers designated by the National Cancer Institute in the United States

For more than 30 years, US News and World Report has ranked the Memorial Sloan Kettering Cancer Center (MSK) as the top 2 cancer hospitals in the United States

MSK Sloan was awarded the 2022 Excellence Award for the Peak of Human Experience and the Guardian of Excellence Award by Press Ganey

MSK Sloan received the 2022 Pinnacle of Excellence Award from Press Ganey in the Patient Experience category. This award recognizes healthcare organizations that consistently maintain high levels of excellence in patient experience, employee engagement, physician engagement, or clinical quality performance. In addition, MSK also received the 2022 Guardian of Excellence Award. Since 2015, MSK has been honored by Press Ganey for providing an outstanding patient experience. Press Ganey is a leading research company and strategic partner organization responsible for assessing patient satisfaction

MSK Sloan was rated by Forbes as one of the top 100 charities in the United States in 2022

Forbes listed MSK as one of the top 100 charities in the United States in 2022. The Forbes list reflects the fiscal year reported by each charity, and the ranking is entirely based on private donations. Government subsidies, service payments, and investment returns are not included, but the total income of each organization is recorded

MSK Sloan selected for Newsweek's "Best Diversified Workplace in America 2023" list

Newsweek named MSK Sloan the best diverse workplace in the United States in 2023. Newsweek and market data research company Plant-A Insight's ratings are based on their review of public data, interviews with human resources professionals, and anonymous online surveys of different employee groups in companies with 1000 or more employees in the United States. Respondents were asked questions to understand their company and to be familiar with the company's corporate culture and work environment. The winning companies are grouped into six major economic sectors and 34 industries

MSK Sloan was selected as the 2023 list of top doctors in Castle Connolly

Castle Connolly has released the 2023 annual list of Castle Connolly's top doctors. This year, 244 MSK Sloan doctors have received this award. Castle Connolly's top doctors are nominated by peers, and the research team evaluates key criteria to determine a list, including professional qualifications, education, hospital and faculty appointments, research leadership, professional reputation, discipline history, interpersonal skills, and outcome data

The Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:

Awards and Appointments

Alexander Rudensky was named Outstanding Researcher in 2023 by the American Society of Immunologists

Dr. Alexander Rudensky, an immunologist at the Sloan Kettering Institute (SKI), was named Outstanding Researcher in 2023 by the American Association of Immunologists (AAI). The association was established in 2019 and annually recognizes outstanding professional and scientific contributions as well as members who provide services to the AAI and immunology communities. Commending outstanding research achievements in the field of immunology; Demonstrate outstanding leadership at the national or international level in academia, foundations, non-profit organizations, industry, or government immunology

Selwyn M. Vickers was selected as one of the top 100 healthcare forces in 2023

MSK President and CEO Selwyn M. Vickers, MD, and FACS were selected as one of the top 100 healthcare forces in New York City in 2023. He is ranked 33rd on this year's list. The ranking recognizes decision-makers in the medical industry in New York, including prominent public officials, influential hospital and healthcare directors, heads of other non-profit providers, union leaders, scholars, and a range of advocates and activists

Samuel Bakhoum received the Emerging Leadership Award from the Mark Cancer Research Foundation

Samuel F. Bakhoum, MD, PhD, radiation oncologist, was awarded the Emerging Leadership Award by the Mark Cancer Research Foundation. Dr. Bakhoum received an award for his project "Examining the connection between chromosomes and epigenetic reprogramming in cancer". This award supports innovative cancer research by leaders and awards outstanding early career researchers to support high impact, high-risk projects that differ from their current research portfolio

MSK Sloan researchers won the 2022 Prostate Cancer Foundation Team Challenge Award

The Prostate Cancer Foundation (PCF) announced the winners of the 2022 PCF Team Challenge Award and a total of over $12 million in innovative prostate cancer research funding. Project leader Howard I. Scher, MD, medical oncologist, and project leader for biomarker development, as well as D. Wayne Callaway, Chairman of Urology and Oncology, Behfar Ehdaie, MD, Master of Public Health, and David Knorr, MD, are recipients of their project "Enhancing antigen presentation and anti-tumor immunity of prostate cancer through intratumoral delivery of Fc enhanced anti CD40 antibody therapy.". The PCF Challenge Award funds an international, multi agency, interdisciplinary team of researchers to conduct highly innovative research that accelerates new and improved therapies for advanced prostate cancer. After a rigorous peer review process to assess the scientific value and potential patient impact of each project, the PCF Challenge Award is awarded to the team of the world's leading cancer research institutions

Urvi A. Shah became the winner of the 2023 Scholar Award of the American Society of Hematology

Urvi A. Shah, MD, a blood oncologist, has been appointed recipient of the American Society of Hematology (ASH) Scholarship Award in 2023. As ASH's most prestigious research award program, the ASH Scholar Award supports industry researchers in the hematology research profession. Each scholar award provides $100000 for researchers, $125000 for researchers to teachers and scholars, or $150000 for junior teachers. The program funds hematologists in the United States and Canada to conduct basic, translational, and clinical research to deepen the understanding and treatment of blood diseases

Mark D. EwaIt became a member of the Molecular Genetic Pathology Test Development and Advisory Committee of the American Pathological Commission in 2023

Mark D. EwaIt, M.D., is a pathologist and director of the Molecular Genetic Pathology Test Pathology Program. He was appointed a member of the Molecular Genetic Pathology Test Development and Advisory Committee (TDAC) of the American Pathology Council (ABPath) in 2023. The committee is responsible for developing and reviewing ABPath certification exam questions, evaluating and certifying the education, knowledge, experience, and skills of doctors, and providing high-quality care in the pathology profession

Jennifer Liu Becomes Director of MSK Sloan Cardiology

Jennifer Liu, MD, FACC, Director of Cardiology, has been appointed Director of MSK Sloan Cardiology. This service provides services for high-risk patients with existing cardiovascular diseases, cancers, or cardiovascular diseases caused by cancer treatment, as well as heart disease during cancer treatment

About Us

In the current era of economic and information globalization, strengthening international communication and cooperation in the medical field is an essential and important way to improve medical quality and build first-class hospitals. As an academic medical service enterprise, EVO Medical actively practices the development strategy of "deep internationalization", and is committed to building an international cooperation and co construction platform to provide services such as talent cultivation, talent introduction, and discipline construction for domestic hospitals and health administrative departments. We will continue to broaden the international medical development path of integration, innovation, and development, and help high-quality development in the international medical field